Principal Investigator
LAWRENCE NEGRET
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20231310
Clinical Trial Summary
Randomized, Open-Label Study Of The BRIA-IMT Regimen And Check Point Inhibitor Vs Physicians Choice In Advanced Metastatic Breast Cancer (BRIA-ABC)
Phase
Phase III
Funding Agency/Sponsor
Industrial
Disease
Breast Cancer
Contact Information
Phone Number
305-243-2647